| Kristen Sampson, MA | |
|
103 Commercial St, Brockton, MA 02302-3133 | |
| (508) 580-4691 | |
| Not Available |
| Full Name | Kristen Sampson |
|---|---|
| Gender | Female |
| Speciality | Psychologist - Cognitive & Behavioral |
| Location | 103 Commercial St, Brockton, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245892769 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TB0200X | Psychologist - Cognitive & Behavioral | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristen Sampson, MA 111 Holt St, Watertown, MA 02472-1019 Ph: () - | Kristen Sampson, MA 103 Commercial St, Brockton, MA 02302-3133 Ph: (508) 580-4691 |
News Archive
Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. However, a study in the October Journal of Lipid Research finds that similar statin drugs can have profoundly different effects on brain cells -both beneficial and detrimental.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe and Eurasia, today announced that The Journal of Urology has electronically published the uncorrected proof of the pivotal IMPRESS (The Investigation for Maximal Peyronie's Reduction Efficacy and Safety Studies) trials on its website.
One-third of all children and adolescents in the United States are overweight or obese. In South Dakota, 32.5 percent of children ages 5 to 19 are overweight or obese. Among Native American children in the state, that number is 48.1 percent.
Epizyme, Inc., a company leading the creation of a new class of personalized therapeutics for patients with genetically defined cancers, announced today that it has initiated a Phase 1 Study of EPZ-5676. EPZ-5676 is a novel small molecule inhibitor of DOT1L, a histone methyltransferase (HMT) that is critical to the development of a specific type of acute leukemia defined by rearrangement of the MLL gene (MLL-r leukemia).
PTC124, an oral medication that changes the way muscle cells interpret genetic information, holds promise as a treatment for some patients with Duchenne muscular dystrophy (DMD), the Muscular Dystrophy Association ( http://www.mda.org/ ) announced today.
› Verified 9 days ago
Dr. Leon J Monnin, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 1350 Belmont Street, Suite 103, Brockton, MA 02301 Phone: 508-580-2137 Fax: 508-559-6143 | |
Dr. Holloway Marston, PSYD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 940 Belmont St Bldg 2, Brockton, MA 02301 Phone: 774-826-3189 | |
Michelle Kovacs, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 940 Belmont St, Brockton, MA 02301 Phone: 813-400-5961 | |
Dr. Heather M. Walton Flynn, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 940 Belmont St, Building 2, Unit 22c, Brockton, MA 02301 Phone: 774-826-1009 | |
Dr. Ronald Paul Travaglione, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 209 Quincy St, Brockton, MA 02302 Phone: 508-584-2291 Fax: 508-584-3480 | |
Dr. Claire Michelle Burgess, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 940 Belmont St, Brockton, MA 02301 Phone: 774-826-1109 Fax: 774-826-2815 | |
Ilannah Deshazier, Psychologist Medicare: Not Enrolled in Medicare Practice Location: 74 Plain St Unit 74j, Brockton, MA 02301 Phone: 508-690-6069 |